Once organizations achieve their profitability and market performance targets, they often focus on additional goals. However, ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer ...

DAREONTM-9, a phase Ib study of obrixtamig plus topotecan in patients (pts) with advanced small cell lung cancer (SCLC): Interim analysis results. Comprehensive longitudinal immune cell monitoring in ...

Darolutamide improved clinically relevant secondary end points of time to castration-resistant prostate cancer and subsequent systemic antineoplastic therapy versus placebo in all disease volume and ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

What this ultimately resulted in was the classification of four autism subgroups. The first two subgroups were noted for displaying high levels of verbal intelligence. One of them, however ...

Researchers have identified three distinct subgroups of Sjögren syndrome (SS) with different prognoses. While previous efforts to stratify these patients were based on reported symptoms ...

Relative survival increased from 64% to 66%, overall survival from 54% to 55%, and lymphoma-specific survival from 64% to 66%.

and weight and baseline GC dose subgroups were also analyzed for GC dose reduction at Week 28. This comprehensive approach allowed for a thorough evaluation of treatment effects across diverse ...

Pandora Dewan is a Senior Science Reporter at Newsweek based in London, UK. Her focus is reporting on science, health and technology. Pandora joined Newsweek in 2022 and previously worked as the ...